Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CEPI: Driving Progress Toward Epidemic Preparedness and Response.

Dimitrios Gouglas, Mario Christodoulou, Stanley A Plotkin

    Epidemiologic Reviews
    |November 2, 2019
    PubMed
    Summary

    The Coalition for Epidemic Preparedness Innovations (CEPI) was formed to develop vaccines for epidemic threats. CEPI has funded vaccine development and partnerships to improve global health security.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pulse oximetry: exploring its role, limitations and challenges in clinical practice.

    Nursing standard (Royal College of Nursing (Great Britain) : 1987)·2026
    Same author

    Why Is Mumps Vaccine not Persistently Effective?

    The Pediatric infectious disease journal·2026
    Same author

    Chikungunya: Unpronounceable, But Important.

    The Pediatric infectious disease journal·2026
    Same author

    Why do we have a vaccine for measles, but not cytomegalovirus (CMV)?

    PLoS pathogens·2026
    Same author

    A Vaccine to Prevent Congenital Cytomegalovirus: Where Do We Go Next?

    JAMA pediatrics·2026
    Same author

    Lessons from COVID-19: the 100 Days Mission and antimicrobial resistance.

    Philosophical transactions of the Royal Society of London. Series B, Biological sciences·2026

    Area of Science:

    • Global Health
    • Vaccinology
    • Epidemiology

    Background:

    • Established post-Ebola outbreak (2014-2015) to address global vaccine preparedness.
    • Mobilized over US$750 million since 2017 for vaccine development.
    • Focuses on epidemic infectious diseases like Lassa virus, MERS-CoV, and Nipah virus.

    Purpose of the Study:

    • To provide an overview of CEPI's mission and achievements.
    • To outline CEPI's future priorities in vaccine research and development.
    • To highlight CEPI's role in fostering public-private partnerships.

    Main Methods:

    • Review of CEPI's funding and strategic initiatives.
    • Analysis of CEPI's portfolio of vaccine candidates and platforms.
    • Description of CEPI's approach to partnerships and resource allocation.
    Keywords:
    CEPILassaMERS-CoVNipahRift Valley feverchikungunyaepidemic infectious diseasesepidemic preparednessglobal health research and development prioritiesvaccines

    Related Experiment Videos

    Main Results:

    • CEPI has supported development of vaccines against priority pathogens and rapid-response platforms.
    • Significant progress in fostering collaborations for vaccine development.
    • Established pathways for vaccine development and manufacturing solutions.

    Conclusions:

    • CEPI has made substantial contributions to global health security through vaccine development and preparedness.
    • Future priorities include portfolio diversification, regulatory pathways, manufacturing, and stockpiling.
    • Continued investment and coordination are crucial for addressing emerging epidemic threats.